Literature DB >> 4613128

Live oral Shigella vaccine: vaccination schedule and the effect of booster dose.

D M Mel, B L Arsic, M L Radovanovic, S A Litvinjenko.   

Abstract

Mesh：

Substances：

Year:  1974        PMID： 4613128

Source DB:  PubMed          Journal:  Acta Microbiol Acad Sci Hung        ISSN： 0001-6187


× No keyword cloud information.
  13 in total

1.  Vaccination with attenuated Neisseria meningitidis strains protects against challenge with live Meningococci.

Authors:  Yanwen Li; Yao-hui Sun; Cathy Ison; Myron M Levine; Christoph M Tang
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

Review 2.  Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road.

Authors:  Myron M Levine; Karen L Kotloff; Eileen M Barry; Marcela F Pasetti; Marcelo B Sztein
Journal:  Nat Rev Microbiol       Date:  2007-07       Impact factor: 60.633

3.  An update on vaccines against Shigella.

Authors:  Shai Ashkenazi; Dani Cohen
Journal:  Ther Adv Vaccines       Date:  2013-09

4.  Safety, immunogenicity, and efficacy in monkeys and humans of invasive Escherichia coli K-12 hybrid vaccine candidates expressing Shigella flexneri 2a somatic antigen.

Authors:  K L Kotloff; D A Herrington; T L Hale; J W Newland; L Van De Verg; J P Cogan; P J Snoy; J C Sadoff; S B Formal; M M Levine
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

5.  Shigella Vaccine Development: Finding the Path of Least Resistance.

Authors:  Wilbur H Chen; Karen L Kotloff
Journal:  Clin Vaccine Immunol       Date:  2016-12-05

Review 6.  New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.

Authors:  M M Levine; J B Kaper; R E Black; M L Clements
Journal:  Microbiol Rev       Date:  1983-12

7.  Antigen-specific IgA B memory cell responses to Shigella antigens elicited in volunteers immunized with live attenuated Shigella flexneri 2a oral vaccine candidates.

Authors:  J K Simon; M Maciel; E D Weld; R Wahid; M F Pasetti; W L Picking; K L Kotloff; M M Levine; M B Sztein
Journal:  Clin Immunol       Date:  2011-03-08       Impact factor: 3.969

8.  Construction and characterization of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine.

Authors:  F R Noriega; J Y Wang; G Losonsky; D R Maneval; D M Hone; M M Levine
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

9.  Monoclonal antibodies specific for Shigella flexneri lipopolysaccharides: clones binding to type IV, V, and VI antigens, group 3,4 antigen, and an epitope common to all Shigella flexneri and Shigella dysenteriae type 1 stains.

Authors:  N I Carlin; A A Lindberg
Journal:  Infect Immun       Date:  1987-06       Impact factor: 3.441

10.  Construction and characterization of bivalent Shigella flexneri 2a vaccine strains SC608(pCFAI) and SC608(pCFAI/LTB) that express antigens from enterotoxigenic Escherichia coli.

Authors:  Ryan T Ranallo; C Piyumi Fonseka; Fred Cassels; Jay Srinivasan; Malabi M Venkatesan
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.